PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: LifeSensors, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Human SUMO-3 Patent Expands LifeSensors' Protein Expression Portfolio - LifeSensors, Inc. expands its intellectual property and protein expression portfolio with its patent, “Human SUMO-3 For Enhancing Protein Expression” (US 8,119,369 B2), awarded by the US Patent and Trademark Office last week - LifeSensors.com
Human SUMO-3 Patent Expands LifeSensors' Protein Expression Portfolio

 

NewswireToday - /newswire/ - Malvern, PA, United States, 2012/03/07 - LifeSensors, Inc. expands its intellectual property and protein expression portfolio with its patent, “Human SUMO-3 For Enhancing Protein Expression” (US 8,119,369 B2), awarded by the US Patent and Trademark Office last week - LifeSensors.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

LifeSensors, Inc., developer and manufacturer of SUMO-fusion technology used to overcome bottlenecks in protein production, expands its intellectual property and protein expression portfolio with its patent,“Human SUMO-3 For Enhancing Protein Expression” (US 8,119, 369 B2), awarded by the United States Patent and Trademark Office last week. The patent covers use of human SUMO-3 as a fusion partner to enhance the expression, solubility and stability of heterologous proteins. SUMOpro-3TM, based on the human SUMO-3 protein, is a valuable protein expression platform for expression in E. coli and eukaryotic host systems.

The Global Biosimilar Market 2010-2014 report from Research and Markets projects a US$ 19.4 Billion market size by 2014. Market growth is fueled by the increased rate of patent expirations for many first generation biotherapeutics, leading to the development of biosimilars of the originals. Additionally, in countries with favorable regulatory processes for biosimilars like the U.S., companies hope to secure greater market shares and profit margins within the biosimilar marketplace.

LifeSensors’ protein expression systems based on SUMO fusions create new opportunities to improve yield and bioactivity of biosimilars while reducing costs inherent in other production schemes. Specifically, the SUMOpro-3 system improves yield, solubility and stability of heterologous proteins in E. coli as well as eukaryotic hosts. In particular, the production of recombinant proteins in Pichia pastoris is highly variable and is greatly influenced by the inherent properties of the protein of interest. Fusion of the heterologous protein to human SUMO-3 helps eliminate this variability. The fusion improves folding and protects from degradation by endogenous proteases; it thereby enhances protein production and generation of a native N-terminus on the protein of interest.

Background: Biotechnology and pharmaceutical companies as well as academic and research institutions worldwide are using LifeSensors’ SUMO technologies. Over 200 peptides and proteins have been successfully expressed, and published, using SUMO fusion systems. These systems include E. coli, yeast, (S. cerevisiae and P. pastoris), insect/BEVS and mammalian (intracellular and secretory) cell expression hosts. Compared with traditional fusion tag technology, the enzymatic activity of SUMO proteases is the most specific and efficient—leading to the key advantage—inexpensive costs for cleaving peptide- and protein-fusions. The company’s growing SUMO portfolio represents cost-efficient and scalable technologies for the development of new and existing products in industrial, research and therapeutic markets.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: LifeSensors, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Human SUMO-3 Patent Expands LifeSensors' Protein Expression Portfolio

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: LifeSensors.com 
610-644-8845 info[.]lifesensors.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any LifeSensors, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From LifeSensors, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)